Varvara Shleptsova

Mrs. Varvara Shleptsova


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
VSVarvara Shleptsova
Varvara Shleptsova
NMN. V. Malyuchenko
N. V. Malyuchenko
MKM. A. Kulikova
M. A. Kulikova
MTM. A. Timofeeva
M. A. Timofeeva
JSJ. V. Shchegolkova
J. V. Shchegolkova
Alexander TonevitskyAlexander Tonevitsky
Alexander Tonevitsky

28 October 2010 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
VSVarvara Shleptsova
Varvara Shleptsova
EGE. S. Grebenyuk
E. S. Grebenyuk
SKS. A. Khaustova
S. A. Khaustova
NON. P. Obraztsova
N. P. Obraztsova
MSMaxim Shkurnikov
Maxim Shkurnikov
ETE. A. Tonevitsky
E. A. Tonevitsky

25 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
VSVarvara Shleptsova
Varvara Shleptsova
Ekaterina NuzhnayaEkaterina Nuzhnaya
Ekaterina Nuzhnaya
NTNatalia Taran
Natalia Taran
ETEvgeny Tatarsky
Evgeny Tatarsky
ANAlexandra Nikolaeva
Alexandra Nikolaeva
NSNatalia Semenova
Natalia Semenova
Background: ARCN1-related syndrome (short stature-micrognathia syndrome, SSMG; OMIM #617164) is an autosomal dominant disorder caused by loss-of-function variants in the ARCN1 gene, which encodes the δ-COP (COPD) subunit of the COPI coatomer complex. The condition is classically characterized by intrauterine growth restriction (IUGR), short stature with rhizomelic shortening, microcephaly, micrognathia, facial dysmorphism, and global developmental delay. Methods: Clinical examination, blood tests and genetic analysis were performed. Whole-exome sequencing and Sanger analysis were conducted, followed by bioinformatics analysis and ACMG-based variant interpretation to identify and characterize the pathogenic variant. Results: We report a male proband with a previously undescribed variant in the ARCN1 gene, presenting with an atypical phenotype. Notably, the patient lacked the classical syndromic features, including short stature, microcephaly, IUGR, and developmental delay. The predominant clinical manifestation was transient hepatic dysfunction occurring during febrile episodes, which resolved between acute events. On physical examination, rhizomelic shortening and dysmorphic facial features, including mild micrognathia, were found. Overall, identified symptoms were mild in severity, which may be associated with the variant’s location within the gene. Conclusions: We describe a novel likely pathogenic variant in the ARCN1 gene associated with a mild phenotype of SSMG. This case expands the phenotypic spectrum of ARCN1-related syndrome and highlights the importance of considering this diagnosis in patients with unexplained recurrent liver injury, even in the absence of classical syndromic features.